-
Product Insights
New![]()
Net Present Value Model: Fate Therapeutics Inc’s FT-819
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Fate Therapeutics Inc’s FT-516
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Fate Therapeutics Inc’s FT-538
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Fate Therapeutics Inc’s FT-596
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Forma Therapeutics Inc’s FT-7051
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Fate Therapeutics Inc’s FT-576
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – FT-576 in Relapsed Multiple Myeloma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.FT-576 in Relapsed Multiple MyelomaDrug Details:FT-576 is under development for the treatment of relapsed / refractor multiple...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – FT-576 in Refractory Multiple Myeloma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.FT-576 in Refractory Multiple MyelomaDrug Details:FT-576 is under development for the treatment of relapsed / refractor multiple...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – FT-011 in Systemic Sclerosis (Scleroderma)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.FT-011 in Systemic Sclerosis (Scleroderma) Drug Details:FT-011 (SHP-627) is under development for the treatment of focal...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – FT-001 in Leber Congenital Amaurosis (LCA)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FT-001 in Leber Congenital Amaurosis (LCA) Drug Details: FT-001 is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – FT-819 in Refractory Chronic Lymphocytic Leukemia (CLL)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.FT-819 in Refractory Chronic Lymphocytic Leukemia (CLL)Drug Details:FT-819 is under development for the treatment of relapsed/refractory...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – FT-011 in Chronic Kidney Disease (Chronic Renal Failure)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.FT-011 in Chronic Kidney Disease (Chronic Renal Failure) Drug Details:FT-011 (SHP-627) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – FT-819 in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.FT-819 in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) Drug Details:FT-819 is under development for...
-
Product Insights
Okayamaken FT – Tsuyama Logistics Facility – Okayama
Equip yourself with the essential tools needed to make informed and profitable decisions with our Okayamaken FT - Tsuyama Logistics Facility - Okayama report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
FT Sirius – Sirius Science and Technology Campus – Krasnodarskiy
Equip yourself with the essential tools needed to make informed and profitable decisions with our FT Sirius - Sirius Science and Technology Campus - Krasnodarskiy report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
HA FT LAUDERDALE – Poinciana Crossing Building – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our HA FT LAUDERDALE - Poinciana Crossing Building - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Ft Lauderdale – The Southport Turning Notch Extension – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our Ft Lauderdale - The Southport Turning Notch Extension - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
ManU NHS FT – MFT Royal Infirmary Redevelopment – Manchester
Equip yourself with the essential tools needed to make informed and profitable decisions with our ManU NHS FT - MFT Royal Infirmary Redevelopment - Manchester report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
CALA Homes/ Celeros FT – Newlands Road Residential Community – Glasgow City
Equip yourself with the essential tools needed to make informed and profitable decisions with our CALA Homes/ Celeros FT - Newlands Road Residential Community - Glasgow City report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Hignett FT – Combe Hay Lane Residential Community – Bath and North East Somerset
Equip yourself with the essential tools needed to make informed and profitable decisions with our Hignett FT - Combe Hay Lane Residential Community - Bath and North East Somerset report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.